Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

LIMNAS Lipid membrane-based biosensors using nanoaggregate substrates probed by advanced optical spectroscopy

Coordinator
The Chancellor Masters and Scholars of the University of Cambridge, United Kingdom
Runs
1 October 2026 to 30 September 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101271943

What the project is doing

In the project's own words, from its summary on CORDIS.

In biosensing, distinguishing weak molecular signals from complex bioenvironments remains a major challenge. Lipid membranes, as essential components of living organisms, provide a fundamental interface where many biological processes originate. Capturing and analysing such signals requires biosensors that are non-invasive, highly sensitive, reproducible, multiplex-capable, and stable under mechanical and chemical stress.

The LIMNAS project will develop a new class of highly sensitive, multifunctional, and robust lipid-membrane-based biosensors using nanoaggregate substrates. It will, for the first time, integrate lipid bilayers with monolayer gold nanoparticle aggregates (MLaggs), a unique nanostructure pioneered at the Nanophotonics Centre, University of Cambridge. Combining this platform with advanced optical techniques, surface-enhanced Raman scattering (SERS) and surface-enhanced hyper Raman scattering (SEHRS), will enable the nanoscale characterization of artificial biomimetic lipid membranes and the monitoring of their dynamic interactions with microenvironments and biologically relevant molecules (ATP, hormones, and small proteins).

Through this fellowship, the researcher will bring expertise in nonlinear optical techniques, lipid membrane imaging, and modelling and characterization of electrical double layers to Cambridge, while acquiring advanced training in plasmonics, SERS, semi-automated optical control, and biosensor development. This two-way transfer of knowledge will promote interdisciplinary training, strengthen career independence, and establish long-term collaborations.

By advancing membrane-based biosensing technologies, LIMNAS will reinforce Europe's leadership in biomedical diagnostics and healthcare innovation, fully aligning with the Horizon Europe Work Programme, in particular Cluster 1 (Health) and Cluster 4 (Digital, Industry and Space).

Topics

Who is involved

OrganisationCityCountryRole
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI